A Phase I Trial on the Relative Bioavailability and Food Effect of HRS-1893 Tablets in Healthy Subjects

NCT07272330 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

38

Enrollment

INDUSTRY

Sponsor class

Conditions

Cardiomyopathy

Interventions

DRUG: HRS-1893 tablet A
DRUG: HRS-1893 tablet B

Sponsor

Shandong Suncadia Medicine Co., Ltd.